Live from ClinicalTrials.gov + Open Targets, fetched 2026-11-12 03:46 UTC. Every row links to its source record.
Postmortem · what the sponsor and named sources said, kept apart from what merely happened at the same time
Pilot Study of Fenofibrate for PSC
NCT01142323 · University of Miami · PHASE1/PHASE2 · terminated · last registry update 2018-02-06 · Decision brief
No research has been run for this trial yet, so only the registry's own reason and the timeline are shown.
No reason was published
Stated is the sponsor's own words; Reported is a named third party. The category is our label from a fixed list; the quote is the evidence.
| Kind | Quote | Our category | Source |
|---|---|---|---|
| Stated | The registry record gives no reason | – | Registry record, University of Miami |
Also happening at the time. Not shown to be a cause.
Registry events on other trials of drugs against PPARA within 12 months either side of this trial's last update, live from ClinicalTrials.gov. Nothing here was stated as a reason.
- 2019-02-01Results posted on the registry: University of Texas Southwestern Medical Center, Gemfibrozil (NCT02638597)
- 2018-10-12Results posted on the registry: Lewai Sharki Abdulaziz, MSc PhD, Fenofibrate (NCT03615534)
- 2018-10-03Results posted on the registry: Eli Lilly and Company, Evacetrapib + Gemfibrozil (NCT01736254)
- 2018-09-25Results posted on the registry: AstraZeneca, Placebo + Omega-3 carboxylic acid (NCT02354976)
- 2018-09-10Phase 3 first posted: Maastricht University Medical Center, Ciprofibrate 100Mg Tablet + Placebo Oral Tablet (NCT03662984)
- 2018-08-07Phase 3 first posted: Hanlim Pharm. Co., Ltd., HL-PIF cap.160/2mg + Placebo + Livalo tab. 2mg + Placebo (NCT03618797)
- 2018-05-07Results posted on the registry: Sanofi, Alirocumab + Placebo (NCT02584504)
- 2018-05-01Results posted on the registry: Sanofi, Alirocumab + Statins (NCT02642159)
- 2018-04-27Phase 3 first posted: Sanofi, Alirocumab SAR236553 (REGN727) + Rosuvastatin (NCT03510884)
- 2018-04-27Phase 3 first posted: Sanofi, Alirocumab SAR236553 (REGN727) + Atorvastatin (NCT03510715)
- 2017-11-17Phase 3 first posted: Jaeb Center for Health Research, Pemafibrate + Placebo (NCT03345901)
- 2017-08-17Also stopped (terminated): VA Office of Research and Development, fenofibrate + pioglitazone (NCT01289639)
- 2017-06-14Results posted on the registry: University of Miami, Fenofibrate (NCT01965834)
- 2017-06-14Also stopped (terminated): University of Miami, Fenofibrate (NCT01965834)
- 2017-06-02Results posted on the registry: The Scripps Research Institute, Sugar Pill + TRICOR (fenofibrate) (NCT02158273)
- 2017-04-20Results posted on the registry: Centre for Addiction and Mental Health, Gemfibrozil + Placebo (NCT01876810)
- 2017-03-15Results posted on the registry: Sanofi, Alirocumab + Placebo (for Alirocumab) (NCT02023879)
- 2017-03-07Phase 3 first posted: Kowa Research Institute, Inc., K-877 + Placebo (NCT03071692)
What is not public
- Internal portfolio and board discussions
- Unpublished trial data and interim analyses
- Terms of any partner or licence decision